Growing Evidence Supports Use of Long-Acting Injectable (LAI) Antipsychotics for Schizophrenia in Adults
National Council for Behavioral Health Guide to Long-Acting Medications for Providers and Organizations (2019)
The National Council for Behavioral Health supports the safe and effective use of LAIs by encouraging mental healthcare professionals to utilize LAIs as an earlier treatment option rather than using them1 only after multiple negative outcomes such as failed oral medications, multiple relapses, or hospitalizations.
Excerpts from The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, Third Edition regarding long-acting injectable antipsychotics (2020)
Click icons below to be directed to excerpts.